2026-04-25

Lilly expands tirzepatide manufacturing capacity

Manufacturing capacity expansion announced.

Reduces brand supply risk for Mounjaro and Zepbound. Compounded supply continues in parallel under shortage rules.

Get matched

Want a real recommendation?

Five minutes. Free. No pressure.

Start my consultation